ZNTL
Zentalis Pharmaceuticals Llc
2.70$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +1,827.8% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | -3.2% | -3.9% | +0.9% | -1.8% | -1.2% | -17.4% | -38.9% | – | – | -3.8% | – | – | |
| – | – | +2,177.1% | -100.8% | – | – | -101.0% | – | – | – | – | – | – | |
| – | +10.2% | -3.8% | -2.4% | -23.9% | -10.5% | -17.4% | +1.3% | -16.9% | +28.5% | -2.6% | +122.5% | – | |
| – | +2.6% | -3.8% | +6.5% | -12.9% | +173.9% | -73.6% | -31.0% | +47.8% | -26.7% | +15.6% | +101.0% | – | |
| – | +8.3% | -4.3% | +0.2% | -21.1% | +49.2% | -40.5% | -21.0% | -6.4% | +10.8% | +0.8% | +118.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -964.3% | – | – | – | – | – | – | – | – | – | |
| – | -535.5% | – | +86.0% | -110.2% | – | – | – | – | – | -72.9% | +115.0% | – | |
| – | – | – | -976.8% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -934.5% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.